Navigation Links
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
Date:12/7/2009

MOUNTAIN VIEW, Calif., Dec. 7 /PRNewswire/ -- In addition to data released in late November, ChemoCentryx, Inc., announced today more data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. While the earlier announcement concerned the Induction period of the study, new data from the Maintenance period of the study showed that a statistically significant number of patients receiving continuous therapy of Traficet-EN versus placebo for 36 weeks were in clinical remission of Crohn's disease, defined as a score of 150 points or less in the Crohn's Disease Activity Index (CDAI). At week 36, a statistically significant percentage of patients receiving Traficet-EN versus placebo were in corticosteroid-free remission. Traficet-EN continued to be safe and well-tolerated after extended use. Additionally, conclusive evidence was provided that the involvement of the CCR9 and its chemokine ligand (TECK) in inflammatory bowel disease (IBD) is not just restricted to the small bowel, but is relevant to inflammation of the large bowel as well.

The new Crohn's disease clinical remission findings, as well as the expanded understanding of the role of CCR9 and its ligand TECK in the gastrointestinal system (GI) tract, were highlighted in poster and oral presentations titled "PROTECT-1 Maintenance Phase Study Results Demonstrate Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease" and "CCR9 Inhibition in the Treatment of Colonic Inflammation" at the 2009 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's Clinical & Research Conference in Hollywood, Florida.

Traficet-EN is an orally-active antagonist of the chemokine receptor known as 'CCR9', which is selectively expressed by inflammatory T cells that migrate to the digestive t
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
2. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
7. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
8. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
11. Pharmasset Reports Fiscal Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  Inari Medical, Inc. announced today that it has ... The financing was led by members of the board ... Venture Partners.  The round also included participation by several ... pleased to complete this financing with the support of ... who joined in February 2015 as President and Chief ...
(Date:6/30/2015)... , June 30, 2015 Today, UBM China, ... an agreement with Chengdu Tianyi Exhibition Co., Ltd. to ... which is to be held concurrently with CWMEE 2016. ... UBM,s healthcare exhibition family, following MEDTEC China and DENTECH ... market in west China. It,s also another concrete cooperative ...
(Date:6/30/2015)... , BERKELEY, Kalifornien, und KOPENHAGEN, Dänemark, 30. ... Inc. , ein Weltmarktführer der klinischen und ... therapeutischen Proteinen, gab heute bekannt, dass das ... Produktionskapazität den Ausbau der nordamerikanischen Produktionsanlage in ... der Ergänzung  einer Einweg-Anlage Bioreactor 6Pack™ komplettiert ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3
... Henry Schein , Inc., (Nasdaq: HSIC ), the largest ... Steven Paladino , the Company,s Executive Vice President and Chief Financial Officer, ... June 17, 2010 . The conference is being held at the Hyatt Regency ... , , ...
... BERLIN and BERGISCH GLADBACH, ... the worldwide release of the Viscover(TM),product line, offering researchers an unrivaled ... , , ... Viscover marks the result of a fruitful collaboration between Miltenyi,Biotec ...
Cached Medicine Technology:Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference 2Miltenyi Biotec Announces Release of Viscover(TM) Preclinical Contrast Agents for in vivo Small Animal Imaging 2Miltenyi Biotec Announces Release of Viscover(TM) Preclinical Contrast Agents for in vivo Small Animal Imaging 3
(Date:6/30/2015)... Los Angeles, California (PRWEB) , ... June 30, ... ... store that specializes in Middle eastern, Persian and Mediterranean foods and groceries. ... orders., Just in time for the BBQ season, http://persianbazzar.com added great ...
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down announces that they have slashed prices across ... legendary Pantages Theatre. For the past 26 years, “The Phantom of the Opera” ... this musical, originally written by Gaston Leroux, and converted into a musical by Andrew Lloyd ...
(Date:6/30/2015)... ... , ... According to research by European archeologists that was recently discussed in ... hundred thousand years ago likely knew that eating a balanced diet and limiting smoke ... dental plaque, researchers were able to find evidence of plant fibers, in addition to ...
(Date:6/30/2015)... Santa Monica, CA (PRWEB) , ... June 30, ... ... release of its new YouTube video, “Fireside Convalescent Care Center.” The video informs ... create the video after continually seeing the need for those seeking care to ...
Breaking Medicine News(10 mins):Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 3Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2
... Cyclist Davis Phinney, Diagnosed with Parkinson,s Disease at ... The DiseaseMINNEAPOLIS, April 09 Medtronic, Inc. (NYSE: ... forces with the Davis Phinney Foundation to raise ... caregivers about how to improve their lives today. ...
... Ensign Group, Inc. (Nasdaq: ENSG ) announced ... in Ogden, Utah has successfully graduated from the Centers ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO )"It was a team effort, and ... we strive to make Mt. Ogden the Ogden area,s ...
... as little as $57 a monthSPRINGFIELD, Ill., April 9 ... College Illinois !(SM) , the state,s ... Incentive Program. With only a few weeks left to ... the decision to enroll easier by giving qualifying purchasers ...
... one of the Largest Union Votes at a Boston ... decades, workers unite for the best patient care, for their families ... St. Elizabeth,s Medical Center, the largest medical center in the Caritas ... election conducted by the National Labor Relations Board, by 73% to ...
... performance cell culture media components will reveal significant advantages of its ... 20-22 in San Francisco. , ... Fort Collins, CO ... culture media components used for mammalian cell culture will be showcased ...
... DIEGO, April 9 CardioDynamics (Nasdaq: CDIC ), the innovator ... fiscal first quarter 2009. Financial Highlights of First ... , , ... a 3% increase excluding large Eastern European hospital group sales in the ...
Cached Medicine News:Health News:Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinson's Disease 2Health News:Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinson's Disease 3Health News:The Ensign Group Successfully Graduates Third Nursing Home From CMS Special Focus Program 2Health News:57 (More) Reasons to Buy a Contract From College Illinois!(SM) 2Health News:57 (More) Reasons to Buy a Contract From College Illinois!(SM) 3Health News:More than 800 Workers at Caritas St. Elizabeth's Medical Center Make History with Vote to join 1199SEIU 2Health News:More than 800 Workers at Caritas St. Elizabeth's Medical Center Make History with Vote to join 1199SEIU 3Health News:InVitria Headlines Sponsorship of WilBio's Waterside Conference 2Health News:CardioDynamics Reports First Quarter 2009 Results 2Health News:CardioDynamics Reports First Quarter 2009 Results 3Health News:CardioDynamics Reports First Quarter 2009 Results 4Health News:CardioDynamics Reports First Quarter 2009 Results 5Health News:CardioDynamics Reports First Quarter 2009 Results 6
All welded construction for strength and durability. Choice of stainless steel or chrome plated models. One forward leg with caster for increased mobility....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Ideal for surgical procedures, these portable stands fit into tight areas for easy instrument access. Easy placement over patient....
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm...
Medicine Products: